Contradicted and initially stronger effects in highly cited
clinical research. JAMA
2005; 294: 218–28.
Pereira, TV, Horwitz, RI, Ioannidis, JP.
Empirical evaluation of very large treatment effects of
medical interventions. JAMA
2012; 308: 1676–84.
Nieminen, P, Rucker, G, Miettunen, J, Carpenter, J, Schumacher, M.
Statistically significant papers in psychiatry were cited
more often than others. J Clin Epidemiol
2007; 60: 939–46.
Hunt, GE, Cleary, M, Walter, G.
Psychiatry and the Hirsch h-index: the relationship between
journal impact factors and accrued citations.
Harv Rev Psychiatry
2010; 18: 207–19.
Trikalinos, TA, Churchill, R, Ferri, M, Leucht, S, Tuunainen, A, Wahlbeck, K, et al.
Effect sizes in cumulative meta-analyses of mental health
randomized trials evolved over time. J Clin
2004; 57: 1124–30.
A rating scale for depression. J
Neurol Neurosurg Psychiatry
Kay, SR, Fiszbein, A, Opler, LA.
The positive and negative syndrome scale (PANSS) for
schizophrenia. Schizophr Bull
1987; 13: 261–76.
Why most published research findings are
false. PLoS Med
2005; 2: e124.
Ho, PM, Peterson, PN, Masoudi, FA.
Evaluating the evidence: is there a rigid
2008; 118: 1675–84.
A simple method for converting an odds ratio to effect size
for use in meta-analysis. Stat Med
2000; 19: 3127–31.
Statistical Power Analysis in the Behavioral Sciences.
Higgins, J, Green, S.
Cochrane Handbook for Systematic Reviews of Interventions (version
5.1.0). Cochrane Collaboration,
In t’ Veld, BA, Ruitenberg, A, Hofman, A, Launer, LJ, van Duijn, CM, Stijnen, T, et al.
Nonsteroidal antiinflammatory drugs and the risk of
Alzheimer's disease. N Engl J Med
2001; 345: 1515–21.
Breitner, JC, Baker, LD, Montine, TJ, Meinert, CL, Lyketsos, CG, Ashe, KH, et al.
Extended results of the Alzheimer's disease anti-inflammatory
prevention trial. Alzheimers Dement
2011; 7: 402–11.
Street, JS, Clark, WS, Gannon, KS, Cummings, JL, Bymaster, FP, Tamura, RN, et al.
Olanzapine treatment of psychotic and behavioral symptoms in
patients with Alzheimer disease in nursing care facilities: a
double-blind, randomized, placebo-controlled trial. The HGEU Study
Group. Arch Gen Psychiatry
2000; 57: 968–76.
De Deyn, PP, Carrasco, MM, Deberdt, W, Jeandel, C, Hay, DP, Feldman, PD, et al.
Olanzapine versus placebo in the treatment of psychosis with
or without associated behavioral disturbances in patients with
Alzheimer's disease. Int J Geriatr
2004; 19: 115–26.
Tohen, M, Jacobs, TG, Grundy, SL, McElroy, SL, Banov, MC, Janicak, PG, et al.
Efficacy of olanzapine in acute bipolar mania: a
double-blind, placebo-controlled study. The Olanzipine HGGW Study
Group. Arch Gen Psychiatry
2000; 57: 841–9.
McIntyre, RS, Cohen, M, Zhao, J, Alphs, L, Macek, TA, Panagides, J.
A 3-week, randomized, placebo-controlled trial of asenapine
in the treatment of acute mania in bipolar mania and mixed
states. Bipolar Disord
2009; 11: 673–86.
Marshall, M, Lockwood, A, Bradley, C, Adams, C, Joy, C, Fenton, M.
Unpublished rating scales: a major source of bias in
randomised controlled trials of treatments for
schizophrenia. Br J Psychiatry
2000; 176: 249–52.
Wood, L, Egger, M, Gluud, LL, Schulz, KF, Juni, P, Altman, DG, et al.
Empirical evidence of bias in treatment effect estimates in
controlled trials with different interventions and outcomes:
meta-epidemiological study. BMJ
2008; 336: 601–5.
Savovic, J, Jones, HE, Altman, DG, Harris, RJ, Juni, P, Pildal, J, et al.
Influence of reported study design characteristics on
intervention effect estimates from randomized, controlled
trials. Ann Intern Med
2012; 157: 429–38.
Replication and p intervals: p values predict the future only
vaguely, but confidence intervals do much better.
Perspect Psychol Sci
Why most discovered true associations are
2008; 19: 640–8.
Leucht, S, Hierl, S, Kissling, W, Dold, M, Davis, JM.
Putting the efficacy of psychiatric and general medicine
medication into perspective: review of meta-analyses.
Br J Psychiatry
Schulz, KF, Chalmers, I, Hayes, RJ, Altman, DG.
Empirical evidence of bias. Dimensions of methodological
quality associated with estimates of treatment effects in controlled
1995; 273: 408–12.